ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Obama Calls for Bigger Investment in Science, GOP Plans Cuts

January 28, 2011

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991

New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White

November 30, 1984

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

July 26, 1985

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005